Intra-Cellular Therapies Inc. buy Mizuho
Start price
22.04.24
/
50%
€70.50
Target price
22.04.25
€90.20
Performance (%)
-5.67%
Price
22:26
€66.50
Summary
This prediction is currently active. With a performance of -5.67%, the BUY prediction by Mizuho is trending in the wrong direction. This prediction currently runs until 22.04.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 0.000% | 0.000% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Mizuho for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Mizuho from $82.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Mizuho for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€71.00
21.06.24
21.06.24
€93.48
21.06.25
21.06.25
-6.34%
22:26
22:26
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.30
17.02.24
17.02.24
€76.07
17.02.25
17.02.25
-5.48%
22:26
22:26